reference/26484118

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26484118

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	9451
issn	1838-7640
issueIdentifier	19
pageRange	9431-9451
publicationName	Theranostics
startingPage	9431
bibliographicCitation	Ni Y, Hu BC, Wu GH, Shao ZQ, Zheng Y, Zhang R, Jin J, Hong J, Yang XH, Sun RH, Liu JQ, Mo SJ. Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI. Theranostics. 2021;11(19):9431–51. PMID: 34646379; PMCID: PMC8490525.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_073502f64563414a434f5c8531145fef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1e39512e594f336b00871a5a905f07b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_baf937c8b366e8275945d11266842157 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0efc43cf4a5b53ce6cc8a72df5b95c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab457aad0d4f2a8505552f5cd3f53dd2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741549313621eeeac07c7212d84b4456 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58ad14c93e3d79a6173791137edb5849 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da76c4c539efccc545830924b6df1022 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3ef3f991ae7f2f41e523967a56b79b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d05c42805cf09008ac9d014f453a5bf4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d92f5fc38318d2c805c0df10e10faa5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f2e4fb6007b3597f7078b565ff9e813
date	2021
identifier	https://pubmed.ncbi.nlm.nih.gov/34646379 https://doi.org/10.7150/thno.61902 https://pubmed.ncbi.nlm.nih.gov/PMC8490525
isPartOf	https://portal.issn.org/resource/ISSN/1838-7640 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38958
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI
discusses	http://id.nlm.nih.gov/mesh/M0012577 http://id.nlm.nih.gov/mesh/M0165848 http://id.nlm.nih.gov/mesh/M000625320 http://id.nlm.nih.gov/mesh/M0284711 http://id.nlm.nih.gov/mesh/M0027627 http://id.nlm.nih.gov/mesh/M000625319
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11261 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10369 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.13.12.8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10308 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eaee9567c029d7e58742804936af793d http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.1.1.37 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6197 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_98f5687ac9f1876ac5902f8a7af125b1

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3202 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8742 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18602 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27279

Total number of triples: 48.